REMPEX PHARMACEUTICALS
Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
REMPEX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.rempexpharma.com
Total Employee:
1001+
Status:
Active
Contact:
8588752851
Total Funding:
67.5 M USD
Technology used in webpage:
Nginx Dingfeng Xinhui Baidu Cloud
Similar Organizations
Cantab Biopharmaceuticals
Cantab Biopharmaceuticals engages in the discovery and development of innovative drugs and drug formulations.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Daniel D. Burgess President & CEO @ Rempex Pharmaceuticals
President & CEO
2011-01-01
Michael Dudley Co-Founder ,SVP of R&D @ Rempex Pharmaceuticals
Co-Founder ,SVP of R&D
Elizabeth Morgan Vice President of Clinical Operations @ Rempex Pharmaceuticals
Vice President of Clinical Operations
2011-01-01
Founder
Investors List
OrbiMed
OrbiMed investment in Series B - Rempex Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series B - Rempex Pharmaceuticals
Vivo Capital
Vivo Capital investment in Series B - Rempex Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - Rempex Pharmaceuticals
SV Health Investors
SV Health Investors investment in Series B - Rempex Pharmaceuticals
Official Site Inspections
http://www.rempexpharma.com Semrush global rank: 3.88 M Semrush visits lastest month: 1.18 K
- Host name: 208.91.197.132
- IP address: 208.91.197.132
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
